Thomas J. Schnitzer
Experienced in Synovitis

Dr. Thomas J. Schnitzer

Rheumatology
Northwestern Medical Group
345 E Superior St 9th Fl, 
Chicago, IL 
Offers Telehealth
55 Years of Experience
Experienced in Synovitis
Northwestern Medical Group
345 E Superior St 9th Fl, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thomas Schnitzer is a Rheumatologist in Chicago, Illinois. Dr. Schnitzer has been practicing medicine for over 55 years and is rated as an Experienced provider by MediFind in the treatment of Synovitis. His top areas of expertise are Arthritis, Osteoporosis, Synovitis, Knee Replacement, and Hip Replacement.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 19 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Synovitis.

Graduate Institution
Harvard Medical School, 1971.0
Residency
Johns Hopkins University
Specialties
Rheumatology
Licenses
Neuromusculoskeletal Medicine, Sports Medicine in IL
Board Certifications
American Board Of Internal Medicine - Internal Medicine (Certified)
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

345 E Superior St 9th Fl, Chicago, IL 60611
Call: 708-923-4963

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy
Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy
Enrollment Status: Completed
Publish Date: December 02, 2025
Intervention Type: Drug
Study Phase: Phase 2
Effects of Romosozumab on Bone Health in Women With Spinal Cord Injury and Osteoporosis
Effects of Romosozumab on Bone Health in Women With Spinal Cord Injury and Osteoporosis
Enrollment Status: Completed
Publish Date: September 24, 2025
Intervention Type: Drug
Study Drugs: Romosozumab, Alendronate
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2024
Intervention Type: Drug
Study Drug: Pentosan Polysulfate Sodium
Study Phase: Phase 2/Phase 3
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
Adaptations of the Brain in Chronic Pain With Opioid Exposure I
Adaptations of the Brain in Chronic Pain With Opioid Exposure I
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2024
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back Pain
Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: October 05, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: August 09, 2023
Intervention Type: Drug
Study Drugs: Sodium Hyaluronate, Triamcinolone Hexacetonide
Study Phase: Phase 3
BRAIN MECHANISMS FOR CLINICAL PLACEBO IN CHRONIC PAIN: A Partially-Blind Randomized Clinical Trial of Placebo and Chronic Back Pain
BRAIN MECHANISMS FOR CLINICAL PLACEBO IN CHRONIC PAIN: A Partially-Blind Randomized Clinical Trial of Placebo and Chronic Back Pain
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Phase: Phase 4
Transcranial Magnetic Stimulation to Enhance Cortical Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain
Transcranial Magnetic Stimulation to Enhance Cortical Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain
Enrollment Status: Withdrawn
Publish Date: February 03, 2023
Intervention Type: Device
Study Phase: Not Applicable
View 16 Less Clinical Trials

94 Total Publications

International Spinal Cord Injury Fracture History Extended Data Set.
International Spinal Cord Injury Fracture History Extended Data Set.
Journal: Topics in spinal cord injury rehabilitation
Published: August 27, 2025
View All 94 Publications
Similar Doctors
Advanced in Synovitis
Dr. Aarti Malik
Rheumatology
Advanced in Synovitis
Dr. Aarti Malik
Rheumatology

Endeavor Health Medical Group

2150 Pfingsten Rd, 
Glenview, IL 
 (18.4 miles away)
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Aarti Malik is a Rheumatologist in Glenview, Illinois. Dr. Malik is rated as a Distinguished provider by MediFind in the treatment of Synovitis. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Psoriasis, and Rheumatoid Arthritis (RA). Dr. Malik is currently accepting new patients.

Advanced in Synovitis
Dr. Chinyoung Park
Rheumatology
Advanced in Synovitis
Dr. Chinyoung Park
Rheumatology

Illinois Bone And Joint Institute, LLC

9000 Waukegan Rd, Suite 200, 
Morton Grove, IL 
 (14.0 miles away)
847-375-3000
Languages Spoken:
English, Korean
See accepted insurances
Offers Telehealth

Chinyoung Park is a Rheumatologist in Morton Grove, Illinois. Dr. Park is rated as an Advanced provider by MediFind in the treatment of Synovitis. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Fibromyalgia, and Necrotizing Vasculitis.

Advanced in Synovitis
Dr. James S. Grober
Rheumatology
Advanced in Synovitis
Dr. James S. Grober
Rheumatology
1000 Central St, Suite 800, 
Evanston, IL 
 (12.2 miles away)
847-570-1206
Languages Spoken:
English
See accepted insurances

James Grober is a Rheumatologist in Evanston, Illinois. Dr. Grober is rated as a Distinguished provider by MediFind in the treatment of Synovitis. His top areas of expertise are Calcium Pyrophosphate Arthritis, Adult Still's Disease, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD).

VIEW MORE SYNOVITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schnitzer's expertise for a condition
ConditionClose
    • Distinguished
    • Arthritis
      Dr. Schnitzer is
      Distinguished
      . Learn about Arthritis.
      See more Arthritis experts
      • Experienced
      • Hip Replacement
        Dr. Schnitzer is
        Experienced
        . Learn about Hip Replacement.
        See more Hip Replacement experts
      • Kienbock's Disease
        Dr. Schnitzer is
        Experienced
        . Learn about Kienbock's Disease.
        See more Kienbock's Disease experts
      • Knee Replacement
        Dr. Schnitzer is
        Experienced
        . Learn about Knee Replacement.
        See more Knee Replacement experts
      • Osteoporosis
        Dr. Schnitzer is
        Experienced
        . Learn about Osteoporosis.
        See more Osteoporosis experts
      • Synovitis
        Dr. Schnitzer is
        Experienced
        . Learn about Synovitis.
        See more Synovitis experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Close
          0 / 1000

          Please provide us with the below insurance information:

                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.